Pregnancy Complications from Herceptin, PERJETA, and KADCYLA

Contact Us to Start Enrollment

Disclaimer

Thank you for submitting your email information.

A registry representative will be in touch with you to finalize enrollment details and respond to any question you may have.

Why Should I Enroll My Patients in This Registry?

Why Should I Enroll My Patients in This Registry?

Herceptin® (trastuzumab), PERJETA® (pertuzumab), or KADCYLA® (ado-trastuzumab emtansine) may cause fetal harm when given to pregnant women. There is not enough data about using these therapies during pregnancy. Please consider adding your patients to this registry. The information collected in this registry can supplement other sources of data and assist you and your patients in making informed treatment decisions.

Do I Need Authorization
From My Patients?